Most patients with stage four cancer are not considered candidates for definitive radiotherapy due to the challenge of treating multiple tumors. Our breakthrough technology is challenging that and aims to treat multiple tumors, in parallel, during a single session.
Treatment isn’t a one-size-fits-all situation. For many patients, the best treatment plan is a combination of multiple therapies. RefleXion will work together with chemotherapy, immunotherapy and targeted drugs for potentially better outcomes.
X1 Machine Rotates up to 60 Times Faster than Other Linear Accelerators for Precise Dose Delivery to Tumors HAYWARD, Calif., March 13, 2020 – RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy (BgRT)* to treat all stages of cancer today announced it has received marketing clearance from the U.S. Food & […]
Biology-Guided Radiotherapy: A New Modality in Cancer Care? When Sam Mazin and Akshay Nanduri met in grade 9 science class at Thornlea Secondary School in Thornhill, Ontario, Canada, neither could have imagined they would one day create a bio-targeting oncology company that is poised to transform cancer care. They became fast friends, continually challenging each […]
In prior posts of this blog, we have approached the story of metastatic cancer from a number of different angles. We discussed what metastatic cancer is, and why it is a deadly disease. We discussed in depth that drugs such as chemotherapy and immunotherapy are the most common treatment for metastatic cancer because they can attack both visible tumors and […]